Company: CDLX
Filing Date: 2025-11-05
Form Type: 10-Q
Source: 0001666071-25-000159
Chunk: 98

Company: Cardlytics, Inc.
Filing Date: 2025-11-05
Form: 10-Q
Item: Item 1
Chunk 98
---
ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

2

Table of Contents

CARDLYTICS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)

(Amounts in thousands, except par value amounts)

September 30, 2025December 31, 2024AssetsCurrent assets:Cash and cash equivalents$43,961 $65,594 Accounts receivable and contract assets, net85,496 103,252 Other receivables5,908 3,801 Prepaid expenses and other assets5,345 5,336 Total current assets140,710 177,983 Long-term assets:Property and equipment, net2,206 2,596 Right-of-use assets under operating leases, net5,328 6,341 Intangible assets, net7,007 11,371 Goodwill110,305 159,429 Capitalized software development costs, net25,595 33,341 Other long-term assets, net1,656 1,650 Total assets$292,807 $392,711 Liabilities and stockholders' equityCurrent liabilities:Accounts payable$3,613 $3,689 Accrued liabilities:Accrued compensation7,295 5,494 Accrued expenses7,474 7,175 Partner Share liability22,153 32,479 Consumer Incentive liability32,109 45,513 Short-term debt46,070 45,863 Deferred revenue and other liabilities3,372 2,154 Current operating lease liabilities1,617 2,025 Current contingent consideration— 4,563 Total current liabilities123,703 148,955 Long-term liabilities:Convertible senior notes, net168,570 167,729 Long-term operating lease liabilities5,176 6,034 Long-term deferred revenue62 — Total liabilities$297,511 $322,718 Stockholders’ equity:Common stock, $0.0001 par value—100,000 shares authorized, 53,806 and 51,257 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively$10 $10 Additional paid-in capital1,393,138 1,366,958 Accumulated other comprehensive (loss) income(2,038)3,